Behavioral profile of amisulpride in agonistic encounters between male mice

Aggressive Behavior

Volumn 25, Issue 3, 1999, Pages 225-232

  Manzaneque, Juan Manuel ^a   Navarro, José Francisco ^a,b  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b Campus de Teatinos   (Spain)

Author keywords

Aggression; Amisulpride; Mice; Motor behavior; Neuroleptics; Subchronic treatment

Indexed keywords

EID: 0033246225     PISSN: 0096140X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2337(1999)25:3<225::AID-AB6>3.0.CO;2-S     Document Type: Article

References (39)

1. Aguilar MA, Miñarro J, Pérez-Iranzo N, Simón VM. 1994. Behavioral profile of raclopride in agonistic encounters between male mice. Pharmacol Biochem Behav 47:753-756.
2. Arregui A, Azpiroz A, Simón VM, Brain PF. 1993. Effects of two dopaminergic selective antagonists on ethologically-assessed conflicts in male mice. Gen Pharmacol 24:353-356.
3. Bischoff S, Bittiger H, Delini-Stula A, Ortmann R. 1988. Septo-hippocampal system: target for substituted benzamides? Eur J Pharmacol 79: 225-232.
4. Bischoll S. 1992. Limbic selective neuroleptics. Clin Neuropharmacol 15(suppl 1):265A-266A.
5. Boyer P, Lecubrier Y, Puech AJ, Laferriere N, Fleurot O. 1992. Treatment of dysthymia with low-dose amisulpride versus amineptine. Clin Neuropharmacol 15(suppl 1):524B.
6. Boyer P, Lecubrier Y, Puech AJ, Dewailly J, Aubin F. 1995. Treatment of negative symptoms in schizophrenia with amisulpride. Br J Psychiatry 166:68-72.
7. Brain PF, Benton D, Childs G, Parmigiani S. 1981. The effect of the opponent in tests of murine aggression. Behav Processes 6:319-328.
8. Brain PF, McAllister KH, Walmsley S. 1989. Drug effects on social behavior: methods in ethopharmacology. In: Boulton AA, Baker GB, Greensha AJ, editors. Neuromethods. Vol. 13. Psychopharmacology. Clifton, NJ: The Humana Press. p 687-739.
9. Brain PF, Kuumorini N, Benton D. 1991. "Anxiety" in laboratory rodents: a brief review of some recent behavioural development. Behav Processes 25:71-80.
10. Dufour A, Desanti C. 1988. Pharmacocinétique et métabolisme de l'amisulpride. Ann Psychiatr 3:298-305.
11. Eilam D, Talangbayan H, Canaran G, Szechtman H. 1992. Dopaminergic control of locomotion, mouthing, snout contact, and grooming: opposing roles of D1 and D2 receptors. Psychopharmacology 106:447-454.
12. Garmendia L, Sánchez JR, Azpiroz A, Brain PF, Simón VM. 1992. Clozapine: strong antiaggressive effects with minimal motor impairment. Physiol Behav 51:51-54.
13. Huck F. 1982. Tiapride in disorders of behaviour in the elderly. La Semaine des Hopitaux 58:2345-2347.
14. Mann K, Bartels H, Bauer H, Gaertner HJ. 1984. Amisulpride: an open clinical study of a new benzamide in schizophrenic patients. Pharmacopsychiatry 17:111-115.
15. Manzaneque JM, Navarro JF. 1999. An ethopharmacological assessment of the effects of zuclopenthixol on agonistc interactions between male mice. Meth Find Exp Clin Pharmacol. In press.
16. Martín-López M, Puigcerver A, Vera F, Navarro JF. 1993. Sulpiride shows anantiaggressive specific effect after acute treatment in male mice. Med Sci Res 21:595-596.
17. Martín-López M, Caño A, Navarro JF. 1996. Efectos de la administración de dosis altas de sulpiride sobre la conducta agonística en ratones machos. Psicothema 8:161-166.
18. Martínez M, Castaño D, Simon V, Brain PF. 1986. An ethopharmacological assessment of the influences of cyproterone acetate on social interactions in male mice. IRSC Med Sci 14:44-45.
19. Martinot JL, Paillere-Martinot ML, Poirier MF, Dao-Castellana MH, Loch C, Maziere B. 1996. In vivo characteristics of dopamine D2 receptor occupancy by amisulpride in schizophrenia. Psychopharmacology 124:154-158.
20. Mattila MJ, Patat A, SeppalaT, Kalska H, Jalava ML, Vanakoski J, Lavanant C. 1996. Single oral doses of amisulpride do not enhance the effects of alcohol on the performance and memory of healthy subjects. Eur J Clin Pharmacol 51:161-166.
21. Mokrim R, Brunet C, Cazin M, Gressier B, Luyck M, Dine T, Robert H, Cazin JC. 1993. Amisulpride evaluation by radioreceptor assay: comparison with HPLC procedure after single administration in the rabbit. Methods Find Exp Clin Pharmacol 15:41-47.
22. Navarro JF. 1997. An ethoexperimental analysis of the agonistic interactions in isolated male mice: comparison between OF.1 and NMRI strains. Psicothema 9:333-336.
23. Navarro JF, Manzaneque JM. 1997. Acute and subchronic effects of tiapride on isolation-induced aggression in male mice. Pharmacol Biochem Behav 58:255-259.
24. Navarro JF, Miñarro J, Simón VM. 1993. Antiaggressive and motor effects of haloperidol show different temporal patterns in the development of tolerance. Physiol Behav 53:1055-1059.
25. Navarro JF, Manzaneque JM, Martín-López M. 1996. Effects of three dopaminergic antagonists (haloperidol, tiapride, zuclopentixol) on grooming behaviour in make mice. Med Sci Res 24:681-682.
26. Navarro JF, Manzaneque JM, Vera F, Martín-López M, Santin LJ. 1997. Amisulpride, a presynaptic D2/D3 dopamine receptor antagonist, induces catalepsy in mice. Med Sci Res 25:551-552.
27. Paillere-Martinot M, Lecubrier Y, Martinot JL, Aubin F. 1995. Improvement of some schizophrenic deficit symptoms with low doses of amisulpride. Am J Psychiatry 152:130-131.
28. Perrault GH, Depoortere R, Morel E, Sanger J, Scatton B. 1997. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity. J Pharmacol Exp Ther 280:273-282.
29. Puigcerver A, Navarro JF, Simón VM. 1996. Sorting out antiaggressive and motor effects of haloperidol by means of tolerance development. Med Sci Res 24:343-345.
30. Redolat R, Brain PF, Simon VM. 1991. Sulpiride has an antiaggressive effect in mice without markedly depressing motor activity. Neuropharmacology 30:41-46.
31. Rodgers RJ. 1997. Animals models of "anxiety": where next? Behav Pharmacol 8:447-496.
32. Scatton B, Perrault G, Gonon G, Depoortere R, Sanger D, Shoemaker H. 1995. Novel neuroleptics acting on presynaptic dopaminergic receptors. Neuropsychopharmacology 5:213S.
33. Shoemaker H, Claustre Y, Page D, Rouquier L, Chergui K, Curet O, Oblin A, Gonon F, Carter C, Benavides J, Scatton B. 1997. Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity. J Pharmacol Exp Ther 280:83-87.
34. Sokoloff P, Andrieux M, Besancon R, Martress MP, Giros B, Schwartz JC. 1992. Pharmacology of human dopamine receptor expressed in a mammalian cell line: comparison with D2 receptor. Eur J Pharmacol 225:331-337.
35. Takahashi M, Akagi M. 1996. Case report of sodium valproate treatment of aggression associated with Alzheimer's disease. NoTo Shinkei 48:757-760.
36. Traqui A, Mutter-Schmidt C, Kintz P, Berton C, Mangin P. 1995. Amisulpride poisoning: a report on two cases. Hum Exp Toxicol 14:294-298.
37. Valzelli L. 1969. Aggressive behavior induced by isolation. In: Garattini S, Sigg EB, editors. Aggressive behaviour. Amsterdam: Excerpta Medica. p 70-76.
38. Vanelle JM, Olie JP, Levy-Soussan P. 1994. New antipsychotics in schizophrenia: the French experience. Acta Psychiatr Scand 380:59-63.
39. Wetzel H, Grunder G, Hillert A, Philipp M, Gattaz WF, Sauer H, Adler G, Schroder J, Rein W, Benkert O. 1998. Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology: a double blind controlled study comparing a selective D2-like antagonist to a mixed D1/D2-like antagonist. Psychopharmacology 137:223-232.